Windlas Biotech Limited (WINDLAS) — Cash Flow Quality Index
Windlas Biotech Limited (WINDLAS) has a Cash Flow Quality Index of 0.45x as of December 2023. Operating cash flow of Rs67.78 Million is below net income of Rs150.98 Million, suggesting accrual-heavy earnings not yet converted to cash. Also explore Windlas Biotech Limited asset portfolio for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Windlas Biotech Limited Cash Flow Quality Index (2018–2025)
Historical Cash Flow Quality Index for Windlas Biotech Limited across 8 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check WINDLAS tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Windlas Biotech Limited (2018–2025)
Year-by-year earnings quality comparison for Windlas Biotech Limited. For live market cap and the full company financial profile, see WINDLAS stock market capitalisation.
| Year | Quality Index | Operating CF (INR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.12x | Rs681.87 Million | Rs609.94 Million | ▼ -40.3% |
| 2024 | 1.87x | Rs1.09 Billion | Rs581.87 Million | ▲ +75.2% |
| 2023 | 1.07x | Rs609.65 Million | Rs570.39 Million | ▲ +433.4% |
| 2022 | 0.20x | Rs91.30 Million | Rs455.65 Million | ▼ -62.0% |
| 2021 | 0.53x | Rs114.54 Million | Rs217.40 Million | ▼ -48.0% |
| 2020 | 1.01x | Rs250.06 Million | Rs246.68 Million | ▲ +313.6% |
| 2019 | 0.25x | Rs186.54 Million | Rs761.15 Million | ▼ -90.7% |
| 2018 | 2.64x | Rs295.91 Million | Rs111.98 Million | — |